V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Senior Director – BSMO Disease Area Lead - Immunology Disease Strategy Team

Biology & BiotechPosted on Nov 11
Full-timeBoston, MA, USA

About the Job

Requirements

  • Strong expertise in biologics development and manufacturing across the lifecycle, including cell-line and upstream cell culture, downstream purification, drug substance, formulation, drug product and fill-finish, and device or combination-product considerations where applicable.
  • Working command of biologics CMC fundamentals, including process and analytical development, control strategy, product and process characterization, comparability and change management, and process validation or PPQ.
  • Understanding of biologics-specific technical risks, including product and process sensitivity, aggregation and immunogenicity, glycosylation and other critical quality attributes, stability, and cold-chain requirements.
  • Solid understanding of CMC, Quality/GMP, Regulatory, and Supply Chain requirements for biologic products, including inspection readiness.
  • Experience with external manufacturing and CDMO oversight for biologic drug substance and drug product, including technology transfer and scale-up.
  • Capability to build cross-functional alignment across R&D, Pharmaceutical and Biopharmaceutical Sciences, Regulatory, Finance, Commercial, and Manufacturing partners.
  • Demonstrated expertise in critical thinking, influence, negotiation, problem-solving, strategic thinking, and leadership in a matrix environment, with proven ability to influence areas not under direct control.
  • Excellent verbal, written, and presentation skills.
  • An advanced degree in a relevant scientific or engineering discipline, such as Biochemistry, Biology or Immunology, Chemical or Biochemical Engineering, or Pharmaceutical Sciences.
  • At least 12 years of experience, or equivalent, in biopharmaceutical development, manufacturing, and supply chain, with substantial hands-on biologics experience.
  • Demonstrated experience leading cross-functional program teams and advancing products through one or more development stages.

Responsibilities

  • Lead development and execution of the BSMO program strategy for Immunology programs, aligned with disease, clinical, and commercial strategies.
  • Represent BSMO on the Immunology Disease Strategy Team, supporting governance, planning, and risk discussions.
  • Provide integrated leadership across Pharmaceutical Sciences, Biopharmaceutical Sciences, CMTO, Quality, Supply Chain, and external partners to ensure program readiness.
  • Partner cross-functionally within BSMO to integrate plans to develop and commercialize biologic disease-area products, ensuring regulatory compliance.
  • Support biologics CMC regulatory strategy and submissions in partnership with Regulatory, including IND/IMPD and BLA/MAA content and health-authority interactions as needed.
  • Lead cross-functional BSMO teams to deliver against program milestones in a matrixed environment, applying a robust understanding of each BSMO function’s role.
  • Build effective partnerships with internal stakeholders within BSMO and across the enterprise.
  • Identify and manage program-level technical, operational, and supply risks for biologic products, ensuring appropriate escalation and mitigation planning.
  • Own BSMO program budgets, forecasts, and resource plans, aligning them with functional and DST priorities (AOP/LRP).
  • Track and communicate program status, KPIs, and risks to BSMO and DST leadership.

Desired Qualifications

  • A PhD and/or MBA is preferred.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs